Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2010-3-4
pubmed:abstractText
Peptide splicing is a newly described mode of production of antigenic peptides presented by MHC class I molecules, whereby two noncontiguous fragments of the parental protein are joined together after excision of the intervening segment. Three spliced peptides have been described. In two cases, splicing involved the excision of a short intervening segment of 4 or 6 aa and was shown to occur in the proteasome by transpeptidation resulting from the nucleophilic attack of an acyl-enzyme intermediate by the N terminus of the other peptide fragment. For the third peptide, which is derived from fibroblast growth factor-5 (FGF-5), the splicing mechanism remains unknown. In this case, the intervening segment is 40 aa long. This much greater length made the transpeptidation model more difficult to envision. Therefore, we evaluated the role of the proteasome in the splicing of this peptide. We observed that the spliced FGF-5 peptide was produced in vitro after incubation of proteasomes with a 49-aa-long precursor peptide. We evaluated the catalytic mechanism by incubating proteasomes with various precursor peptides. The results confirmed the transpeptidation model of splicing. By transfecting a series of mutant FGF-5 constructs, we observed that reducing the length of the intervening segment increased the production of the spliced peptide, as predicted by the transpeptidation model. Finally, we observed that trans-splicing (i.e., splicing of fragments from two distinct proteins) can occur in the cell, but with a much lower efficacy than splicing of fragments from the same protein.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1550-6606
pubmed:author
pubmed:issnType
Electronic
pubmed:day
15
pubmed:volume
184
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3016-24
pubmed:meshHeading
pubmed-meshheading:20154207-Amino Acid Sequence, pubmed-meshheading:20154207-Animals, pubmed-meshheading:20154207-Antigen Presentation, pubmed-meshheading:20154207-Antigens, pubmed-meshheading:20154207-COS Cells, pubmed-meshheading:20154207-Cell Line, pubmed-meshheading:20154207-Cell Line, Tumor, pubmed-meshheading:20154207-Cercopithecus aethiops, pubmed-meshheading:20154207-Cytotoxicity Tests, Immunologic, pubmed-meshheading:20154207-Fibroblast Growth Factor 5, pubmed-meshheading:20154207-Humans, pubmed-meshheading:20154207-Molecular Sequence Data, pubmed-meshheading:20154207-Peptide Fragments, pubmed-meshheading:20154207-Proteasome Endopeptidase Complex, pubmed-meshheading:20154207-Protein Precursors, pubmed-meshheading:20154207-Protein Processing, Post-Translational, pubmed-meshheading:20154207-Protein Splicing, pubmed-meshheading:20154207-Transfection
pubmed:year
2010
pubmed:articleTitle
Splicing of distant peptide fragments occurs in the proteasome by transpeptidation and produces the spliced antigenic peptide derived from fibroblast growth factor-5.
pubmed:affiliation
Ludwig Institute for Cancer Research, Brussels Branch and de Duve Institute, Université Catholique de Louvain, Brussels, Belgium.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't